kabutan

Cytori Cell Research Institute, Last Fiscal Year Net Income Loss Widened in Downward Revision, 77% Deficit Against Net Assets

Wed Apr 30, 2025 12:00 pm JST Revision

3750 ADR120S,Inc. 【J-GAAP】

Guidance Update Report

Cytori Cell Research Institute,Inc. <3750> [TSE Std] announced a performance revision at noon (12:00) on April 30th. The consolidated net income/loss for the fiscal year ending March 2025 has been revised downward from an expected loss of 1.03 billion yen to a loss of 2.14 billion yen (compared to a profit of 0.13 billion yen in the previous period), indicating an expansion in the loss margin The deficit amounted to a 76.6% impairment of net assets at the end of the previous fiscal year.. However, the full-year consolidated ordinary profit/loss has been revised upward from an expected loss of 0.91 billion yen to a loss of 0.86 billion yen (compared to a loss of 0.9 billion yen in the previous period), indicating a reduction in the loss margin.

Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated net income/loss has been revised downward from an expected loss of 0.6 billion yen to a loss of 1.7 billion yen (compared to a profit of 0.58 billion yen in the same period of the previous year), indicating an expansion in the loss margin.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 34 -454 -498 -601 -67.3 0 Feb 14, 2025 J-GAAP
Oct - Mar, 2024 New 31 -399 -445 -1,708 -191.3 0 Apr 30, 2025 J-GAAP
Revision Rate -8.8% +12.1% +10.6% -184.2% -184.2%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 125 -861 -917 -1,033 -115.7 0 Feb 14, 2025 J-GAAP
Mar, 2025 New 122 -806 -864 -2,140 -239.7 0 Apr 30, 2025 J-GAAP
Revision Rate -2.4% +6.4% +5.8% -107.2% -107.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 698 -418 -483 581 65.1 0 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 31 -399 -445 -1,708 -191.3 0 Apr 30, 2025 J-GAAP
YoY -95.6% +4.5% +7.9% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,144 -794 -862 -1,059 -118.7 0 May 12, 2023 J-GAAP
Mar, 2024 1,560 -772 -906 138 15.5 0 May 14, 2024 J-GAAP
Mar, 2025 Guidance 122 -806 -864 -2,140 -239.7 0 Apr 30, 2025 J-GAAP
YoY -92.2% -4.4% +4.6% － －

Related Articles